Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Treasury Shares (2019 - 2025)

Historic Treasury Shares for BridgeBio Pharma (BBIO) over the last 6 years, with Q3 2025 value amounting to $323.3 million.

  • BridgeBio Pharma's Treasury Shares rose 1755.49% to $323.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $323.3 million, marking a year-over-year increase of 1755.49%. This contributed to the annual value of $275.0 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, BridgeBio Pharma's Treasury Shares stood at $7.6 million, which was up 2269.81% from $7.6 million recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Treasury Shares registered a high of $7.6 million during Q1 2025, and its lowest value of $759993.0 during Q1 2021.
  • Its 5-year average for Treasury Shares is $5.8 million, with a median of $6.2 million in 2021.
  • In the last 5 years, BridgeBio Pharma's Treasury Shares soared by 26666.67% in 2021 and then changed by 0.0% in 2022.
  • Over the past 5 years, BridgeBio Pharma's Treasury Shares (Quarter) stood at $275.0 million in 2021, then changed by 0.0% to $275.0 million in 2022, then changed by 0.0% to $275.0 million in 2023, then changed by 0.0% to $275.0 million in 2024, then increased by 17.55% to $323.3 million in 2025.
  • Its Treasury Shares was $323.3 million in Q3 2025, compared to $323.3 million in Q2 2025 and $323.3 million in Q1 2025.